MARKET

DBD

DBD

Diebold Nixdorf
NYSE
45.69
+1.46
+3.30%
Closed 16:09 11/22 EST
OPEN
44.50
PREV CLOSE
44.23
HIGH
45.75
LOW
43.89
VOLUME
207.79K
TURNOVER
0
52 WEEK HIGH
51.81
52 WEEK LOW
23.74
MARKET CAP
1.72B
P/E (TTM)
77.38
1D
5D
1M
3M
1Y
5Y
1D
Diebold Nixdorf to Participate in Fireside Chat at UBS Global Industrials and Transportation Conference
PR Newswire · 3d ago
Diebold Nixdorf Expands Services Contract With Marks & Spencer For 4 More Years
NASDAQ · 3d ago
Diebold’s services contract with Marks & Spencer expanded for 4 years
TipRanks · 3d ago
Marks & Spencer Renews and Expands Services Contract with Diebold Nixdorf
PR Newswire · 3d ago
Weekly Report: what happened at DBD last week (1111-1115)?
Weekly Report · 6d ago
Q3 Earnings Outlook: Excluding Health Care, Growth Soften
Seeking Alpha · 11/17 07:55
Frank Baur Spends US$220k Buying Diebold Nixdorf Shares
Simply Wall St · 11/15 10:16
Wednesday 11/13 Insider Buying Report: ROK, DBD
NASDAQ · 11/13 15:57
More
About DBD
Diebold Nixdorf, Incorporated provides a portfolio of solutions designed to automate, digitize and transform the way people bank and shop. The Company's segments include Banking and Retail. Its Banking segment provides integrated solutions for financial institutions of all sizes. The Banking portfolio products consists of cash recyclers and dispensers, intelligent deposit terminals, teller automation, and kiosk technologies. Its DN Vynamic software is an end-to-end software portfolio in the banking marketplace designed to simplify and enhance the consumer experience. The Retail segment offers a portfolio of retail services and products that improves the checkout process for retailers while enhancing shopping experiences for consumers. The retail product portfolio includes self-checkout (SCO) products and ordering kiosks. DN Vynamic software suite for retailers provides a comprehensive, modular and open solution ranging from the in-store check-out to solutions across multiple channels.

Webull offers Diebold Nixdorf Inc stock information, including NYSE: DBD real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, DBD stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading DBD stock methods without spending real money on the virtual paper trading platform.